Clinical & Experimental Immunology Issues Research Articles in January 2023 Edition
March 20, 2023
March 20, 2023
HOBOKEN, New Jersey, March 20 -- Clinical and Experimental Immunology, a peer-reviewed journal from the British Society for Immunology that says it features scientific studies to the treatment, prevention or diagnosis of human disease, posted research articles on the following topics in its January 2023 edition:
Autoimmunity/Autoimmune Disease:
* A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced ar . . .
Autoimmunity/Autoimmune Disease:
* A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced ar . . .